VIPR2 Antikörper
-
- Target Alle VIPR2 Antikörper anzeigen
- VIPR2 (Vasoactive Intestinal Peptide Receptor 2 (VIPR2))
-
Reaktivität
- Human, Ratte, Maus
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser VIPR2 Antikörper ist unkonjugiert
-
Applikation
- ELISA, Immunohistochemistry (IHC)
- Produktmerkmale
- Polyclonal Antibody
- Aufreinigung
- Affinity purification
- Immunogen
- Synthetic peptide of human VIPR2
- Isotyp
- IgG
- Top Product
- Discover our top product VIPR2 Primärantikörper
-
anti-Vasoactive Intestinal Peptide Receptor 2 (VIPR2) (AA 81-170) antibody
VIPR2 Reaktivität: Human, Ratte WB, ELISA, FACS Wirt: Kaninchen Polyclonal unconjugated
anti-Vasoactive Intestinal Peptide Receptor 2 (VIPR2) (Internal Region) antibodyVIPR2 Reaktivität: Human, Ratte, Maus WB, ELISA, IHC, IF, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Vasoactive Intestinal Peptide Receptor 2 (VIPR2) (AA 95-123), (N-Term) antibodyVIPR2 Reaktivität: Human WB Wirt: Kaninchen Polyclonal RB36748 unconjugated
anti-Vasoactive Intestinal Peptide Receptor 2 (VIPR2) (AA 24-126) antibodyVIPR2 Reaktivität: Human WB, ELISA Wirt: Maus Polyclonal unconjugated
anti-Vasoactive Intestinal Peptide Receptor 2 (VIPR2) (AA 24-126) antibodyVIPR2 Reaktivität: Human WB, ELISA Wirt: Maus Monoclonal 2E3 unconjugated
anti-Vasoactive Intestinal Peptide Receptor 2 (VIPR2) (Internal Region) antibodyVIPR2 Reaktivität: Human, Rind (Kuh), Affe, Gorilla IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Vasoactive Intestinal Peptide Receptor 2 (VIPR2) (AA 25-37), (Extracellular), (N-Term) antibodyVIPR2 Reaktivität: Human, Ratte, Maus WB, IF, ICC, FACS, LCI Wirt: Kaninchen Polyclonal unconjugated
anti-Vasoactive Intestinal Peptide Receptor 2 (VIPR2) (AA 24-126) antibodyVIPR2 Reaktivität: Human WB, ELISA Wirt: Kaninchen Polyclonal unconjugated
anti-Vasoactive Intestinal Peptide Receptor 2 (VIPR2) (C-Term) antibodyVIPR2 Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- IHC 1:25-100, ELISA 1:2000-5000
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.3 mg/mL
- Buffer
- PBS with 0.05 % sodium azide and 50 % glycerol, PH7.4
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Target
- VIPR2 (Vasoactive Intestinal Peptide Receptor 2 (VIPR2))
- Andere Bezeichnung
- VIPR2 (VIPR2 Produkte)
- Synonyme
- C16DUPq36.3 antikoerper, DUP7q36.3 antikoerper, PACAP-R-3 antikoerper, PACAP-R3 antikoerper, VIP-R-2 antikoerper, VPAC2 antikoerper, VPAC2R antikoerper, VPCAP2R antikoerper, VIPR2 antikoerper, LOC100136266 antikoerper, Vip2 antikoerper, pacap antikoerper, vpac2 antikoerper, vpac2-R antikoerper, vpac2-r antikoerper, vpcap2r antikoerper, LOC100229999 antikoerper, vasoactive intestinal peptide receptor 2 antikoerper, vasoactive intestinal polypeptide receptor type 2 antikoerper, VIPR2 antikoerper, LOC100136266 antikoerper, Vipr2 antikoerper, vipr2 antikoerper
- Hintergrund
- This gene encodes a receptor for vasoactive intestinal peptide, a small neuropeptide. Vasoactive intestinal peptide is involved in smooth muscle relaxation, exocrine and endocrine secretion, and water and ion flux in lung and intestinal epithelia. Its actions are effected through integral membrane receptors associated with a guanine nucleotide binding protein which activates adenylate cyclase.
- NCBI Accession
- NP_003373
- UniProt
- P41587
- Pathways
- cAMP Metabolic Process
-
